145 related articles for article (PubMed ID: 27055882)
1. SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes.
Sinha N; Yadav AK; Kumar V; Dutta P; Bhansali A; Jha V
Mol Biol Rep; 2016 May; 43(5):345-8. PubMed ID: 27055882
[TBL] [Abstract][Full Text] [Related]
2. SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes.
Lin HY; Wang CL; Hsiao PJ; Lu YC; Chen SY; Lin KD; Hsin SC; Hsieh MC; Shin SJ
Diabetes; 2007 Apr; 56(4):1177-80. PubMed ID: 17229939
[TBL] [Abstract][Full Text] [Related]
3. Association of SUMO4 M55V and -94ins/del gene variants with type-2 diabetes.
Sozen S; Horozoglu C; Bireller ES; Karaali Z; Cakmakoglu B
In Vivo; 2014; 28(5):919-23. PubMed ID: 25189908
[TBL] [Abstract][Full Text] [Related]
4. No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease.
Jennings CE; Owen CJ; Wilson V; Pearce SH
Clin Endocrinol (Oxf); 2005 Mar; 62(3):362-5. PubMed ID: 15730420
[TBL] [Abstract][Full Text] [Related]
5. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
Rudofsky G; Schlotterer A; Humpert PM; Tafel J; Morcos M; Nawroth PP; Bierhaus A; Hamann A
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):14-7. PubMed ID: 17926234
[TBL] [Abstract][Full Text] [Related]
6. Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients.
Sedimbi SK; Shastry A; Park Y; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():273-7. PubMed ID: 17130565
[TBL] [Abstract][Full Text] [Related]
7. Association of SUMO4 M55V polymorphism with type 1 diabetes in Chinese children.
Sang Y; Zong W; Liu M; Yan J
J Pediatr Endocrinol Metab; 2010 Oct; 23(10):1083-6. PubMed ID: 21158221
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population.
Tsurumaru M; Kawasaki E; Ida H; Migita K; Moriuchi A; Fukushima K; Fukushima T; Abiru N; Yamasaki H; Noso S; Ikegami H; Awata T; Sasaki H; Eguchi K
J Clin Endocrinol Metab; 2006 Aug; 91(8):3138-43. PubMed ID: 16735488
[TBL] [Abstract][Full Text] [Related]
9. Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population.
Noso S; Fujisawa T; Kawabata Y; Asano K; Hiromine Y; Fukai A; Ogihara T; Ikegami H
J Clin Endocrinol Metab; 2007 Jun; 92(6):2358-62. PubMed ID: 17374705
[TBL] [Abstract][Full Text] [Related]
10. No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects.
Fallah S; Jafarzadeh M; Hedayati M
Diabetes Res Clin Pract; 2010 Nov; 90(2):191-5. PubMed ID: 20728233
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism M55V in gene encoding small ubiquitin-like modifier 4 (SUMO4) protein associates with susceptibility to type 1 (and type 2) diabetes.
Tang ST; Peng WJ; Wang CJ; Tang HQ; Zhang Q
Diabetes Metab Res Rev; 2012 Nov; 28(8):679-87. PubMed ID: 22936652
[TBL] [Abstract][Full Text] [Related]
12. Association of tumor necrosis factor (TNF) promoter polymorphisms with plasma TNF-α levels and susceptibility to diabetic nephropathy in North Indian population.
Gupta S; Mehndiratta M; Kalra S; Kalra OP; Shukla R; Gambhir JK
J Diabetes Complications; 2015 Apr; 29(3):338-42. PubMed ID: 25704106
[TBL] [Abstract][Full Text] [Related]
13. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis.
Gibbons LJ; Thomson W; Zeggini E; Worthington J; Barton A; Eyre S; Donn R; Hinks A
Rheumatology (Oxford); 2005 Nov; 44(11):1390-3. PubMed ID: 16159953
[TBL] [Abstract][Full Text] [Related]
14. Uromodulin rs4293393 T>C variation is associated with kidney disease in patients with type 2 diabetes.
Kumar V; Yadav AK; Kumar V; Bhansali A; Jha V
Indian J Med Res; 2017 Nov; 146(Suppol):S15-S21. PubMed ID: 29578190
[TBL] [Abstract][Full Text] [Related]
15. Association between the SUMO4 M55V Polymorphism and Susceptibility to Type 2 Diabetes Mellitus: A Meta-analysis.
Zhang Q; Liu D; Zhao ZY; Sun Q; Ding LX; Wang YX
Biomed Environ Sci; 2017 Apr; 30(4):288-295. PubMed ID: 28494838
[TBL] [Abstract][Full Text] [Related]
16. Comment on: Lin et al. (2007) SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes: Diabetes 56: 1177-1180.
Rudofsky G; Schlotterer A; Nawroth PP; Bierhaus A; Hamann A
Diabetes; 2007 Aug; 56(8):e11; author reply e12-3. PubMed ID: 17660269
[No Abstract] [Full Text] [Related]
17. Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of Type 2 diabetes mellitus in Taiwan.
Lin HY; Li SL; Yu ML; Hsiao PJ; Hsieh MC; Lin KD; Wang CL; Wang TN; Shin SJ
J Endocrinol Invest; 2010 Jun; 33(6):401-5. PubMed ID: 19915388
[TBL] [Abstract][Full Text] [Related]
18. Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes.
Yadav AK; Kumar V; Dutta P; Bhansali A; Jha V
J Diabetes; 2014 Nov; 6(6):547-55. PubMed ID: 24433479
[TBL] [Abstract][Full Text] [Related]
19. No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients.
Sedimbi SK; Kanungo A; Shastry A; Park Y; Sanjeevi CB
Int J Immunogenet; 2007 Apr; 34(2):137-42. PubMed ID: 17373940
[TBL] [Abstract][Full Text] [Related]
20. Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: a meta-analysis.
Song GG; Choi SJ; Ji JD; Lee YH
Hum Immunol; 2012 Oct; 73(10):1055-9. PubMed ID: 22884980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
